NEW YORK, June 10-The Cambridge, Mass.-based bioinformatics firm Xpogen said today that it had issued two new licenses to its PathlinX 2.0 analytic software.
The Genomics Center of Beth Israel Deaconess Medical Center in Boston, which provides genomic lab serves to research organizations, and Cambridge-based Genstruct will use the software in their work.
PathlinX integrates gene, phenotype and other data.